ESMO 2024 Insights: Quantitative High Sensitivity HER2 Testing With Trastuzumab Deruxtecan in mBC

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Find latest Breast videos · 900+ videos

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

10 seconds

Playback speed

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

This video is featured in the 2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: Quantitative High Sensitivity HER2 Testing With Trastuzumab Deruxtecan in mBC

By 2024 ESMO Annual Meeting Insights Hub FEATURING Paolo Tarantino

372 views

October 1, 2024

Comments 0

2024 ESMO Annual Meeting Insights Hub: Breast Videos

ESMO 2024 Insights: Identification of Racial Disparities Across Mamm…

2024 ESMO Annual Meeting Insights Hub

W. Audeh

52 views

Quality-Adjusted Time Without Symptoms or Toxicity Analysis of Sacit…

2024 ESMO Annual Meeting Insights Hub

A. Brufsky

48 views

ESMO 2024 Insights: Adjuvant Ribociclib + NSAI in HR+/HER2- eBC - 4-…

2024 ESMO Annual Meeting Insights Hub

P. Fasching

94 views

View All

Oncology Clinical Updates - Review and Renew

Sat, Apr 5, 2025

SABCS 2024 Insights: DESTINY-Breast06 - Monday Morning Practice

2024 SABCS Annual Meeting Insights Hub

S. Tolaney, H. Rugo

2.2K views

Year in Review 2024: Top Metastatic Breast Cancer Trials

Oncology 2024 Year in Review

V. Kaklamani

1.7K views

Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

2.3K views

SABCS 2024 Noteworthy Abstracts in Metastatic Breast Cancer

Sara Tolaney

H. Rugo

1.4K views

FDA Approval Clinical Implications: Inavolisib With Palbociclib and …

Memorial Sloan Kettering Cancer Center

K. Jhaveri

1.2K views

SABCS 2024 Summary: Key Updates From the EMBER-3, PATINA, TAILORx, I…

2024 SABCS Annual Meeting Insights Hub

M. Gatti-Mays

989 views

ASCO® 2024 Breast Cancer Highlights - Monday Morning Practice

2024 ASCO® Annual Meeting Insights Hub

S. Tolaney, H. Rugo

5.1K views

SABCS 2024 Noteworthy Abstracts in Early Breast Cancer

Sara Tolaney

H. Rugo

1.1K views

ESMO 2024 Summary: Top 5 Breast Cancer Abstracts - NATALEE, DESTINY-…

2024 ESMO Annual Meeting Insights Hub

P. Tarantino

1.5K views

SABCS 2024 Insights: PATINA - Monday Morning Practice

2024 SABCS Annual Meeting Insights Hub

S. Tolaney, H. Rugo

664 views

ESMO 2024 Insights: Treatment Rechallenge After Grade 1 Trastuzumab-…

2024 ESMO Annual Meeting Insights Hub

K. Natsuhara

1.4K views

SABCS 2024 Summary: mBC Key Trial Highlights Including PATINA and EM…

2024 SABCS Annual Meeting Insights Hub

A. Brufsky

601 views

ASCO® 2024 Breast Cancer Highlights: Top 5 Abstracts - DESTINY-Breas…

2024 ASCO® Annual Meeting Insights Hub

P. Tarantino

2.5K views

Strategies for Managing Toxicities of Oral Oncolytics in Breast Canc…

UNC Lineberger Comprehensive Cancer Center

A. Faso, B. Patel, K. Chen

1.9K views

The 2023 ASCO®/CAP Guideline Update on HER2 Testing/Classification: …

Shabnam Jaffer

1.1K views

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

2024 ASCO® Annual Meeting Insights Hub

E. Hamilton

1.9K views

SABCS 2024 Summary: William McGuire Memorial Lecture - Advancing Pre…

2024 SABCS Annual Meeting Insights Hub

L. van ’t Veer

437 views

ESMO 2024 Summary: Highlights in mBC

2024 ESMO Annual Meeting Insights Hub

G. Bianchini

739 views

Trastuzumab Deruxtecan's Efficacy Across HER2 Expression Levels in m…

Fernanda Mosele

587 views

NATALEE Trial Impact on eBC: Ribociclib + ET as Adjuvant Treatment i…

Jan-Willem Henning

626 views

AUTOPLAY

Login

Login

Join VuMedi

ESMO 2024 Insights: Quantitative High Sensitivity HER2 Testing With Trastuzumab Deruxtecan in mBC

2024 ESMO Annual Meeting Insights Hub: Breast Videos

ESMO 2024 Insights: Identification of Racial Disparities Across Mamm…

Quality-Adjusted Time Without Symptoms or Toxicity Analysis of Sacit…

ESMO 2024 Insights: Adjuvant Ribociclib + NSAI in HR+/HER2- eBC - 4-…

Related Videos

Oncology Clinical Updates - Review and Renew

SABCS 2024 Insights: DESTINY-Breast06 - Monday Morning Practice

Year in Review 2024: Top Metastatic Breast Cancer Trials

Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

SABCS 2024 Noteworthy Abstracts in Metastatic Breast Cancer

FDA Approval Clinical Implications: Inavolisib With Palbociclib and …

SABCS 2024 Summary: Key Updates From the EMBER-3, PATINA, TAILORx, I…

ASCO® 2024 Breast Cancer Highlights - Monday Morning Practice

SABCS 2024 Noteworthy Abstracts in Early Breast Cancer

ESMO 2024 Summary: Top 5 Breast Cancer Abstracts - NATALEE, DESTINY-…

SABCS 2024 Insights: PATINA - Monday Morning Practice

ESMO 2024 Insights: Treatment Rechallenge After Grade 1 Trastuzumab-…

SABCS 2024 Summary: mBC Key Trial Highlights Including PATINA and EM…

ASCO® 2024 Breast Cancer Highlights: Top 5 Abstracts - DESTINY-Breas…

Strategies for Managing Toxicities of Oral Oncolytics in Breast Canc…

The 2023 ASCO®/CAP Guideline Update on HER2 Testing/Classification: …

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

SABCS 2024 Summary: William McGuire Memorial Lecture - Advancing Pre…

ESMO 2024 Summary: Highlights in mBC

Trastuzumab Deruxtecan's Efficacy Across HER2 Expression Levels in m…

NATALEE Trial Impact on eBC: Ribociclib + ET as Adjuvant Treatment i…